EQT

Founded in 2018, Perfuze is a medical device company based in Galway, Ireland. It specializes in developing catheter-based aspiration technology designed to treat acute ischemic stroke efficiently and effectively.

Founded in 2019, Noema Pharma is a biotechnology company based in Basel, Switzerland. It specializes in developing innovative therapies for orphan neurological disorders characterized by imbalanced neuronal networks, aiming to improve patient outcomes and quality of life.

NUA Surgical is an award-winning company based in Galway, Ireland, developing and manufacturing surgical instruments for obstetrics and gynecology. Its patented disposable C-section retractor is designed to improve ergonomics and safety during caesarean deliveries, aiming to reduce complications and support safer care for mothers and infants.

Calisen plc is a company based in Manchester, United Kingdom, that owns and manages essential energy infrastructure assets. It operates through two primary business units: Calvin Capital and Lowri Beck. Calvin Capital focuses on procuring, owning, and managing a portfolio of electricity and gas meters, primarily smart meters, for energy retailers. Meanwhile, Lowri Beck provides installation, meter reading, maintenance services, and ancillary support, such as customer service and call center operations, also on behalf of energy retailers. Calisen aims to capitalize on the UK government's initiative to roll out smart meters and is committed to supporting a cleaner and more sustainable energy sector by offering innovative services, including electric vehicle charging solutions. The company was incorporated in 2020.

PageUp People Limited is a provider of a cloud-based talent management platform designed to assist organizations in effectively managing various human resource functions. Founded in 1980 and headquartered in Melbourne, Australia, the company offers a comprehensive suite of services that includes recruitment, onboarding, performance management, learning and development, succession planning, and analytics. Its platform enables clients to streamline their talent management processes, providing tools for hiring, employee training, and career tracking. PageUp serves a diverse range of clients, including major organizations such as AEGIS, AngloAmerican, and National Australia Bank, and has established additional offices in Sydney, Singapore, Hong Kong, New York, and London.

OX2 is a company focused on providing renewable energy solutions, including the development and sale of wind and solar farms. They operate in several countries across Europe, such as Sweden, Finland, Poland, France, Lithuania, Norway, Spain, Italy, Estonia, and Romania. In addition to their core activities in solar and onshore and offshore wind farms, OX2 is also involved in energy storage projects and the development of hydrogen solutions. The company emphasizes technical and business management solutions to support its various energy initiatives.

Sequana Medical is a Swiss medical device company based in Zurich that specializes in developing and commercializing implantable pump systems to manage fluid balance within the body. The company's flagship product, the Alfapump System, is designed to automatically and continually remove ascites, which is excess fluid that accumulates in the abdominal cavity due to advanced liver disease, certain cancers, or congestive heart failure. This system moves the excess fluid to the bladder for natural elimination through urination. Sequana Medical's technology also has potential applications in managing pleural effusions in lung disease patients and fluid overload in those with end-stage renal disease and congestive heart failure. The company was founded in 2006 and has additional offices in Munich, Germany.

AMCS Group is an Irish company specializing in integrated software and technology solutions for the waste, recycling, and resource management industries. Established in 2002 by James Martin and Austin Ryan, AMCS offers a range of products including weighing and RFID technology, mobile computing solutions, and ERP software designed to optimize business processes and improve customer service.

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, founded in 2005. The company specializes in developing diagnostic instruments and disposable cartridge systems for decentralized laboratory and point-of-care settings. Its flagship product, the binx io platform, is the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhea in both males and females, delivering results comparable to central laboratory performance within approximately thirty minutes. Binx Health aims to enhance healthcare access by addressing traditional barriers and extending outreach through its point-of-care diagnostic solutions. The company also focuses on providing rapid polymerase chain reaction (PCR)-based results and a comprehensive digital program that includes evidence-based testing, counseling, treatment, and follow-up services. Binx Health has established a strategic partnership with Sherlock Biosciences, further strengthening its commitment to improving community health outcomes.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly focusing on antibody-drug conjugates (ADCs). The company aims to create transformative chemotherapeutic medications that are tailored to combat cancer and chronic diseases. By integrating proprietary technologies with disease-specific biology, Tubulis develops unique protein-drug combinations that enable clinicians to treat patients while minimizing the adverse effects typically associated with traditional chemotherapy. Through its innovative approach, Tubulis seeks to improve therapeutic outcomes and enhance the safety of cancer treatments.

Phagenesis develops a medical device for treating dysphagia, a swallowing disorder often resulting from stroke or brain injury. The device, Phagenyx, uses neurostimulation therapy to harness the brain's capacity for relearning lost functions via neuroplasticity. It consists of a base station and a catheter inserted through the nose, delivering optimal stimulations to the pharynx while recording patient data.

InstaVolt Ltd is a UK-based company that specializes in the development, construction, ownership, and operation of electric vehicle (EV) charging stations. Incorporated in 2016 and headquartered in Basingstoke, InstaVolt is committed to enhancing the accessibility and convenience of EV charging across the country. The company installs and maintains rapid charging units at various locations, including retail and food service sites, allowing landowners to generate rental income while providing EV drivers with efficient charging options. InstaVolt operates on an open charger model, enabling users to access charging points on a pay-as-you-go basis without the need for subscriptions or membership cards. With a focus on improving air quality and reducing carbon emissions, InstaVolt aims to alleviate range anxiety, a significant barrier to EV adoption, by ensuring that rapid charging points are readily available throughout the UK.

Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.

AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.

Xeltis is a clinical-stage medical device company developing bio-absorbable heart valves and blood vessels. Its RestoreX technology enables the body's natural healing system to create functional tissue within its devices, forming new valves or vessels over time. Headquartered in Zurich, Switzerland, with R&D and manufacturing facilities in Eindhoven, Netherlands, Xeltis aims to transform cardiovascular care.

IntegrityNext is a Munich-based company founded in 2016 by Martin Berr-Sorokin that specializes in supply chain compliance and sustainability monitoring. The company offers a cloud-based platform that enables businesses to oversee their suppliers' compliance with regulatory requirements, thereby reducing risk. Its platform automates the collection of supplier self-assessments and certificates, while also monitoring social media for potential malpractice and reputational threats. With features such as automated risk alerts, a pre-built supplier questionnaire, and a real-time dashboard, IntegrityNext assists small and medium-sized enterprises in translating complex compliance data requirements from international regulations into effective processes and systems. This comprehensive approach to supply chain compliance supports organizations in achieving greater transparency and accountability in their operations.

Xeltis is a clinical-stage medical device company developing bio-absorbable heart valves and blood vessels. Its RestoreX technology enables the body's natural healing system to create functional tissue within its devices, forming new valves or vessels over time. Headquartered in Zurich, Switzerland, with R&D and manufacturing facilities in Eindhoven, Netherlands, Xeltis aims to transform cardiovascular care.

va-Q-tec is a high-tech company established in 2001, specializing in innovative insulation solutions, particularly through vacuum insulation panels (VIPs). The company's products are designed to enhance energy efficiency and are environmentally friendly, making them suitable for various applications. va-Q-tec's technology significantly reduces energy costs in diverse sectors, including the transportation of pharmaceutical products, refrigeration and freezing appliances, construction, and automotive and aerospace industries. The company operates through several segments, with a strong presence in Germany and across the European Union. Its customer base spans multiple industries, including healthcare, logistics, appliances and food, construction, and technical sectors.

Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.

EQT is a global private equity firm founded in Sweden in 1994. It invests across various sectors, including industrials, technology, healthcare, and real estate, with a focus on Northern and Eastern Europe, Asia, and the US. EQT's investment strategies include buyouts, expansion capital, infrastructure investments, and growth equity. The firm seeks to create long-term value by working closely with management teams to unlock growth potential.

Founded in 1989, SHL Medical specializes in designing, developing, and manufacturing advanced drug delivery systems. These include auto injectors, pen injectors, and inhalers for global pharmaceutical and biotechnology companies.

Founded in 2005, Storytel is a leading provider of audiobook and e-book streaming services, offering unlimited access to consumers across over 20 markets. The company's extensive library includes books in multiple languages, catering to diverse reading preferences.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

eTheRNA Immunotherapies NV is a Belgium-based biotechnology company that specializes in the development of mRNA-based immunotherapies. Founded in 2013 and located in Niel, the company focuses on harnessing the immune system's dendritic cells to create treatments for melanoma, triple-negative breast cancer, and infectious diseases. eTheRNA has developed innovative TriMix technology that enhances the immune response, enabling patients to better combat these diseases. The company aims to be a leader in nucleic acid-based medicines, collaborating with partners to facilitate the creation of new drugs and improve patient outcomes. Additionally, eTheRNA has established a strategic partnership with China Grand Pharmaceutical and Healthcare Holdings Limited to further its mission.

FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals. The company works at the nexus of haptics, machine learning, and immersive technologies (XR). FundamentalVR was established in 2012 by Chris Scattergood in London, England.

Envirotainer AB specializes in the production, development, and rental of active temperature-controlled containers designed for the air transportation of temperature-sensitive healthcare products. Established in 1986 and headquartered in Upplands Väsby, Sweden, the company has built a reputation as a global leader in secure cold chain solutions for the pharmaceutical industry. Envirotainer provides a range of services, including laboratory testing, qualification and validation support, data collection, and training through its Qualified Envirotainer Program. The company's extensive network includes operations centers in key locations such as Singapore, Dallas, Frankfurt, and Toronto, as well as a station in Hyderabad, India. By leveraging its innovative container solutions and global presence, Envirotainer meets the critical needs of pharmaceutical and biotech clients for reliable shipping solutions that maintain the integrity of temperature-sensitive products.

Ardoq AS, established in 2013 and headquartered in Oslo, Norway, with offices in New York, London, and Copenhagen, specializes in developing solutions to document and visualize complex computer systems. Its flagship product, Ardoq, combines textual documentation with interactive visualizations, offering features such as automatic visualization generation, real-time collaboration, and model-based documentation. Ardoq serves a wide range of professionals, including business users, developers, project managers, and stakeholders, empowering them to understand interdependencies, plan changes, and make data-driven decisions. The platform enables the entire organization to contribute to documentation, fostering a collaborative environment for digital transformation.

InstaVolt Ltd is a UK-based company that specializes in the development, construction, ownership, and operation of electric vehicle (EV) charging stations. Incorporated in 2016 and headquartered in Basingstoke, InstaVolt is committed to enhancing the accessibility and convenience of EV charging across the country. The company installs and maintains rapid charging units at various locations, including retail and food service sites, allowing landowners to generate rental income while providing EV drivers with efficient charging options. InstaVolt operates on an open charger model, enabling users to access charging points on a pay-as-you-go basis without the need for subscriptions or membership cards. With a focus on improving air quality and reducing carbon emissions, InstaVolt aims to alleviate range anxiety, a significant barrier to EV adoption, by ensuring that rapid charging points are readily available throughout the UK.

Founded in 2018, Perfuze is a medical device company based in Galway, Ireland. It specializes in developing catheter-based aspiration technology designed to treat acute ischemic stroke efficiently and effectively.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

AviadoBio focuses on developing transformative gene therapies for devastating neurodegenerative disorders such as frontotemporal dementia and amyotrophic lateral sclerosis. The company's platform combines proprietary technologies with a deep understanding of the brain to deliver effective treatments.

EQT is a global private equity firm founded in Sweden in 1994. It invests across various sectors, including industrials, technology, healthcare, and real estate, with a focus on Northern and Eastern Europe, Asia, and the US. EQT's investment strategies include buyouts, expansion capital, infrastructure investments, and growth equity. The firm seeks to create long-term value by working closely with management teams to unlock growth potential.

Founded in 2020, Egle Therapeutics is a biotechnology company based in Paris, France. It specializes in developing immunotherapies targeting immune suppressor regulatory T-cells (Tregs) for oncology and autoimmune diseases.

Formo is Europe's first cellular agriculture company developing animal-free dairy products. It uses precision fermentation to derive real, nature-identical milk proteins, offering sustainable and ethical alternatives for consumers.

Founded in 2005, Storytel is a leading provider of audiobook and e-book streaming services, offering unlimited access to consumers across over 20 markets. The company's extensive library includes books in multiple languages, catering to diverse reading preferences.

Cardior Pharmaceuticals GmbH is a biotechnology company based in Hanover, Germany, founded in 2016. The company specializes in developing non-coding RNA-based therapeutics aimed at treating and preventing heart disease, which is the leading cause of death in the western world. Its primary focus is on CDR-132X, an oligonucleotide-based inhibitor that targets a critical microRNA responsible for pathological changes in the heart resulting from stress or injury. Through its innovative approach, Cardior Pharmaceuticals seeks to address significant unmet medical needs in cardiovascular health.

PRO Unlimited Inc. specializes in developing contingent workforce management solutions tailored for Global and Fortune 500 companies. Founded in 1991 and headquartered in Boca Raton, Florida, the company offers a vendor-neutral Managed Services Program that assists clients in effectively managing the procurement, selection, engagement, and tracking of various contingent workers, including independent contractors, consultants, and freelancers. PRO Unlimited also provides a software-as-a-service platform known as Vendor Management System (VMS), which centralizes the management of contingent workforce activities, statement of work engagements, and independent contractor utilization, thereby enhancing quality control, cost management, and compliance. Additionally, its RatePoint application delivers on-demand rate and hiring intelligence for professional contingent positions. The company's solutions address critical challenges such as supplier management, worker classification, lifecycle tracking, and 1099 management. With locations in the United Kingdom, Japan, California, New York, and Hong Kong, PRO Unlimited is well-positioned to meet the evolving needs of the contingent workforce marketplace.

Mollie is a technology-driven payments platform that enables merchants to integrate online payments quickly through a single, developer-friendly API. It processes payments for more than 50,000 clients and supports a broad range of local and global methods, including Mastercard, Visa, Amex, PayPal, iDEAL, Bancontact, SEPA Direct Debit, Giropay, SOFORT Banking, and other options. The platform emphasizes simplicity and reliability, offering features such as single-click payments, fraud monitoring, multicurrency processing, daily settlement management, and real-time accounting to streamline checkout, reduce costs, and manage funds on one platform. Mollie focuses on continuous innovation and ease of integration and is based in Amsterdam, the Netherlands.

Solarpack is an independent solar photovoltaic power producer that specializes in the development and operation of large-scale solar projects. Established in 2005 and headquartered in Getxo, Vizcaya, Spain, the company offers a comprehensive range of services, including financing, construction, and management of utility-scale solar plants. With a total operational capacity of 160 MW across 13 plants and asset management services for an additional 302 MW, Solarpack has a diversified geographical presence, employing over 140 people in 10 countries. The company aims to contribute to sustainable energy infrastructure while fostering social development within the communities it serves by creating economic value and promoting quality employment through its initiatives.

Parcel2Go is the UK's largest online parcel delivery service, offering a comprehensive range of courier services for both home and business users. The company operates a parcel delivery comparison platform that provides an alternative to traditional postal services. By collaborating with major partners such as FedEx, TNT, UPS, and Hermes, Parcel2Go enables customers to send packets and parcels of various sizes to destinations within the UK and internationally. Their platform allows users to manage orders online, track shipments, and access affordable delivery options, streamlining the shipping process for individuals and businesses alike.

Anticimex is a global specialist in preventive pest control, headquartered in Stockholm, Sweden, with operations in 17 countries across Europe, Asia-Pacific, and the United States. The company employs approximately 4,500 staff and serves over 3 million customers worldwide. Anticimex offers a comprehensive range of services, including extermination, environmental maintenance, and hygiene solutions, aimed at both businesses and consumers. In addition to traditional pest control methods, the company features innovative offerings such as Anticimex SMART, a digital pest control solution, and pest insurance, enabling clients to maintain pest-free environments and protect their production facilities effectively.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, founded in 2005. The company specializes in developing diagnostic instruments and disposable cartridge systems for decentralized laboratory and point-of-care settings. Its flagship product, the binx io platform, is the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhea in both males and females, delivering results comparable to central laboratory performance within approximately thirty minutes. Binx Health aims to enhance healthcare access by addressing traditional barriers and extending outreach through its point-of-care diagnostic solutions. The company also focuses on providing rapid polymerase chain reaction (PCR)-based results and a comprehensive digital program that includes evidence-based testing, counseling, treatment, and follow-up services. Binx Health has established a strategic partnership with Sherlock Biosciences, further strengthening its commitment to improving community health outcomes.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Epidemic Sound AB is a Swedish music company founded in 2009, specializing in providing royalty-free music for individuals and businesses globally. The company boasts a diverse catalog of over 30,000 tracks spanning more than 180 genres, including acoustic, classical, and electronic, among others. Epidemic Sound caters to a wide range of customers, including video creators, broadcasters, and production companies, by offering subscription services for unlimited music use or the option to license individual tracks outright. All music provided comes with comprehensive rights clearance for use across all platforms and countries without the need for reporting, ensuring a straightforward licensing process. Headquartered in Stockholm, with additional offices in major cities worldwide, Epidemic Sound aims to empower storytellers by providing high-quality soundtracks that enhance visual content.

CYE offers a cybersecurity optimization platform that helps businesses evaluate, quantify, and mitigate cyber risks. Utilizing AI-driven technology, CYE continuously assesses external security posture of third parties to manage supply chain attack risks. Serving Fortune 500 and mid-market companies globally, CYE is headquartered in Israel with offices in New York and London.

IVC Evidensia is a prominent provider of veterinary services, operating a vast network of over 2,600 hospitals and clinics across Europe. Founded in 2011, the company employs more than 41,000 veterinarians, nurses, referral specialists, and other staff dedicated to animal care. IVC Evidensia emphasizes a decentralized approach that encourages innovation and clinical flexibility while also offering integrated support services, such as purchasing assistance and veterinary consultancy. The company is committed to guiding pet owners on balanced nutrition tailored to the specific needs of their animals, regardless of breed, age, or gender.

Founded in 2015, Neurent Medical is a medical device company based in Galway, Ireland. It specializes in developing non-surgical treatments for chronic rhinitis using minimally invasive, hand-held radio-frequency devices.

NewAmsterdam Pharma, established in 2019 and headquartered in Naarden, the Netherlands, is a late-stage biopharmaceutical company dedicated to improving patient care in cardio-metabolic disease populations. The company's primary focus is the development of transformative therapies, with its lead product, obicetrapib, being a next-generation, oral, low-dose CETP inhibitor designed to lower LDL-C levels more effectively than current treatments, particularly for patients with statin intolerance or Arteriosclerotic Cardiovascular Disease/Familial Hypercholesterolemia (ASCVD/FH) on maximally-tolerated statin therapy.

Molslinjen is a privately held company specializing in ferry services between Jutland and the island of Zealand. The company operates domestic ferry lines and floating bridges, providing essential marine transportation services. Utilizing a fleet of catamaran ferries, Molslinjen facilitates efficient and comfortable travel for passengers, as well as vehicles such as cars, trucks, and buses. Its large car decks allow for easy boarding and disembarking, enhancing the overall travel experience. By prioritizing speed and convenience, Molslinjen plays a vital role in connecting regions and supporting local transportation needs.

Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.

Casa.it S.r.l. is an online property portal based in Milan, Italy, founded in 1996. The company specializes in providing information related to real estate agencies and listings for properties available for sale or rent, including flats, villas, independent houses, penthouses, and lofts. Casa.it serves as a platform for both real estate professionals and private individuals to access and advertise real estate opportunities, facilitating connections between buyers, sellers, and renters in the Italian market.

Idealista operates an online property portal that serves agents and private individuals in Spain, Italy, and Portugal. The platform functions as a digital real estate marketplace, providing buyers and sellers with essential real-time information to facilitate property transactions. By offering a user-friendly interface, Idealista helps alleviate the challenges associated with finding a home, thus supporting millions of users in their real estate endeavors. Additionally, the company allows property owners to advertise their listings through a subscription model, enabling them to reach a broader audience while accessing valuable market insights.

Colisée is a prominent entity in the health care sector, specializing in the care and well-being of elderly individuals. The company operates over 90 retirement homes and nearly 70 home-based service agencies across France, Italy, and Spain. By focusing on both nursing home and home care services, Colisée provides essential daily care to residents and patients, as well as support for their families. With a workforce exceeding 6,700 employees, the organization is committed to delivering quality care tailored to the needs of the aging population.

Founded in Stockholm, Sweden in 2019, Depict is developing an AI-driven platform that enhances e-commerce product recommendations using advanced neural networks and computer vision. It analyzes real-time shopper behavior to provide actionable insights on product performance, helping fashion and retail businesses improve customer engagement and drive sales.

Lumeon Ltd. is a digital health company based in London, United Kingdom, specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and previously known as Qinec Ltd., Lumeon offers a cloud-based platform called Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. The platform enables healthcare providers to unify clinical and administrative workflows, automate tasks, and deliver measurable care, addressing the underlying systems that drive healthcare transformation. Lumeon's clientele includes some of Europe's leading healthcare providers, such as BUPA and Nuffield Health, reflecting its position as a key player in the market. The company employs over 90 professionals dedicated to enhancing patient care through effective management and analysis of healthcare pathways.

Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Cybin is a biopharmaceutical company dedicated to advancing research and development in psychedelic and medicinal mushrooms. It focuses on creating safe and effective therapeutics for mental health issues, with an emphasis on psilocybin-based products. The company is actively launching these products in jurisdictions where they are permitted and is engaged in clinical studies across North America and other regions. Through strategic partnerships with academic and institutional entities, Cybin seeks to develop novel compounds and delivery mechanisms, aiming to provide innovative treatments for various psychiatric and neurological conditions.

Founded in 2010, Freepik Company is a pioneering digital platform that empowers creative professionals with AI-driven tools for high-quality audiovisual content generation. Its extensive library of over 250 million assets enables users to transform ideas into visuals swiftly and efficiently.

Kiadis Pharma N.V. is a clinical-stage biopharmaceutical company based in Amsterdam, the Netherlands, specializing in the development of cell-based immunotherapy products for blood cancers and inherited blood disorders. The company is currently advancing its product pipeline, which includes K-NK002, an adjunctive immunotherapeutic in Phase II trials for blood cancer patients undergoing haploidentical hematopoietic stem cell transplants, and K-NK003, which is in Phase I/II trials for patients with acute myeloid leukemia who are relapsed or refractory. Additionally, Kiadis Pharma is developing K-NK00X, a preclinical NK-cell therapy candidate aimed at treating various solid tumors. The company is engaged in collaborative efforts with multiple institutions to explore innovative treatments, including a combination of a monoclonal antibody and natural killer cells for COVID-19. Established in 1997, Kiadis Pharma addresses critical unmet medical needs in oncology through its innovative therapeutic approaches.

FoRx Therapeutics is a biotechnology company focused on developing cancer therapies by targeting DNA replication stress. It seeks to drug key molecular targets involved in replication stress to create targeted anticancer drugs. Founded in 2019 and based in Basel, Switzerland, the company emphasizes a novel approach by targeting DNA replication stress pathways activated in cancer cells, with the goal of delivering first-in-class therapies that address the underlying mechanisms of tumor growth.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks aimed at rural and suburban areas. As a pioneering provider in the industry, the company focuses on delivering fiber-to-the-home (FTTH) connections to private households, businesses, and public institutions. By collaborating closely with municipalities, Deutsche Glasfaser aims to facilitate nationwide broadband expansion, contributing significantly to Germany's digital progress. The company is recognized for its innovative and cost-efficient approaches to fiber optic deployment, positioning itself as a technology leader in the market. With substantial backing from experienced investors, Deutsche Glasfaser has emerged as one of the strongest providers in Germany's telecommunications landscape.

RIMES Technologies Corporation specializes in providing cloud-based managed data services and regulatory technology solutions for financial institutions worldwide. The company offers a range of services, including benchmark data, reference data management, environmental, social, and governance (ESG) data solutions, and RegTech offerings such as market surveillance and regulation control. By catering to investment managers, hedge funds, banks, and sovereign funds, RIMES helps clients reduce costs associated with financial data management while enhancing operational efficiency and compliance. Founded in 1996 and headquartered in New York, RIMES operates several locations globally, including in Boston, Toronto, London, and Shanghai, making it a prominent player in the managed data services sector.

Founded in 1989, SHL Medical specializes in designing, developing, and manufacturing advanced drug delivery systems. These include auto injectors, pen injectors, and inhalers for global pharmaceutical and biotechnology companies.

Recover Nordic Norge is the leading provider of emergency response and damage control services in the Nordic region. The company specializes in managing and mitigating the effects of various incidents, ensuring swift and effective recovery solutions for affected individuals and organizations. With a strong presence in the market, Recover Nordic Norge plays a crucial role in addressing emergencies and restoring operations, demonstrating its commitment to service excellence and community support.

CTEK Group, headquartered in Sweden, specializes in manufacturing and distributing high-quality battery chargers for diverse vehicles, focusing on the premium segment. They offer a range of 12V battery chargers alongside solutions for electric vehicle charging, positioning themselves as one of Sweden's leading suppliers in this sector.

iSTAR Medical specializes in developing ophthalmic implants made from biomaterials. Its flagship product is the STARflo glaucoma implant, a non-degradable, precision-pore device designed to reduce intraocular pressure in open angle glaucoma patients by enhancing natural fluid outflow. The company's products are sold through distributors worldwide and it operates from its eco-friendly R&D and manufacturing facility near Namur, Belgium.

AM Pharma B.V. is a biopharmaceutical company based in Bunnik, the Netherlands, focused on developing and commercializing novel therapeutics for inflammatory and infectious diseases. Established in 2000, the company specializes in pre-clinical and clinical development using endogenous proteins and peptides derived from the human body. Its key products include alkaline phosphatase, aimed at treating acute kidney injury and ulcerative colitis, and the immune response amplifying peptide hLF1-11, which targets drug-resistant hospital-acquired infections. AM Pharma is committed to providing innovative therapies that enhance patient quality of life by addressing critical medical needs.

Epidemic Sound AB is a Swedish music company founded in 2009, specializing in providing royalty-free music for individuals and businesses globally. The company boasts a diverse catalog of over 30,000 tracks spanning more than 180 genres, including acoustic, classical, and electronic, among others. Epidemic Sound caters to a wide range of customers, including video creators, broadcasters, and production companies, by offering subscription services for unlimited music use or the option to license individual tracks outright. All music provided comes with comprehensive rights clearance for use across all platforms and countries without the need for reporting, ensuring a straightforward licensing process. Headquartered in Stockholm, with additional offices in major cities worldwide, Epidemic Sound aims to empower storytellers by providing high-quality soundtracks that enhance visual content.

Imcyse SA is a clinical-stage biopharmaceutical company based in Liège, Belgium, specializing in innovative immunotherapeutic solutions aimed at treating severe chronic autoimmune diseases. Founded in 2010, Imcyse is pioneering a unique technology platform that employs Imotopes™, specifically modified peptides that target immune cells responsible for organ damage. This approach facilitates the generation of cytolytic CD4 T-cells, which selectively eliminate antigen-presenting cells and autoantigen-specific lymphocytes, thereby addressing diseases with limited treatment options. The company has shown proof of concept across various indications and has completed its initial clinical trial for type 1 diabetes, yielding promising outcomes. In addition to type 1 diabetes, Imcyse is actively developing a pipeline of therapies for multiple autoimmune diseases, aiming to provide effective treatment while preserving overall immune defense.

Melita is a Maltese telecommunications company offering converged quadruple-play services. It provides high-speed internet, 4.5G mobile networks, Wi-Fi mesh networks, digital television, fixed telephony, and mobile services to households and businesses across Malta. Additionally, Melita owns and operates an undersea submarine optical fiber cable and a Tier 3 co-location data center.

Dellner Couplers AB is a Swedish manufacturer specializing in train connection systems, with over 75 years of experience in the rail industry. The company provides a range of products, including couplers, gangways, hatches, dampers, and crash management systems, designed to enhance safety and reliability in passenger rail travel. In addition to its core manufacturing capabilities, Dellner Couplers offers a variety of after-sales services, such as upgrades, modernization, repairs, technical support, training, and maintenance. With a global presence through subsidiaries, branches, and agents, Dellner Couplers serves train builders and operators both in Sweden and internationally. Founded in 1941 and headquartered in Falun, Sweden, the company operates as a subsidiary of Dellner Invest AB.

SNIPR Biome is a biotechnology company developing CRISPR-based therapies for treating microbial diseases. Founded in 2017 and headquartered in Copenhagen, Denmark, the company leverages CRISPR technology to selectively eliminate harmful bacteria by targeting their specific DNA sequences.

WS Audiology A/S is a manufacturer and distributor of hearing instruments and audiological solutions, headquartered in Lynge, Denmark. Established in 2019 through a partnership between Sivantos and Widex, the company aims to enhance hearing care for individuals with hearing needs. Its product offerings include a comprehensive range of hearing aids, such as receiver-in-the-ear devices, assistive listening devices, and solutions for single-sided deafness. Additionally, WS Audiology provides accessories like hearing aid batteries, remote controls, and electronic drying stations. The company's diverse product spectrum caters to various price categories, ensuring that those with hearing loss have access to effective solutions for improved hearing and understanding.

Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.

Lumeon Ltd. is a digital health company based in London, United Kingdom, specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and previously known as Qinec Ltd., Lumeon offers a cloud-based platform called Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. The platform enables healthcare providers to unify clinical and administrative workflows, automate tasks, and deliver measurable care, addressing the underlying systems that drive healthcare transformation. Lumeon's clientele includes some of Europe's leading healthcare providers, such as BUPA and Nuffield Health, reflecting its position as a key player in the market. The company employs over 90 professionals dedicated to enhancing patient care through effective management and analysis of healthcare pathways.

Founded in 1933, Saur SAS is the third largest company in France’s water distribution and wastewater management sector. It supplies drinking water to millions of residents and manages wastewater treatment across the country. In addition to these core services, the company has expanded into municipal waste collection and treatment, and provides ancillary services to local authorities.

Finclude is a company that has developed a pan-European credit scoring system aimed at enabling businesses to evaluate consumers' creditworthiness based on their transactional behavior, irrespective of their credit history. The platform aggregates and interprets transactional data from various banks, allowing for a comprehensive assessment of an individual's affordability and creditworthiness. This innovative approach assists customers in making informed credit decisions by providing a clearer view of potential borrowers' financial behaviors and capabilities. Finclude's solution addresses the limitations of traditional credit scoring methods, thereby expanding access to credit for a broader range of individuals.

Veritas Petroleum Services provides testing, inspection and advisory solutions for the maritime sector, supported by five laboratories worldwide. It delivers fuel quality testing, bunker quantity surveys, oil condition monitoring and transformer oil testing, along with additional testing services and decarbonisation support. Through these offerings, the company helps clients optimize fuel management, reduce fuel costs, improve operational efficiency and ensure compliance with marine fuel regulatory requirements.

HyTest Ltd. is a manufacturer of monoclonal antibodies and antigens specifically for the diagnostic industry, founded in 1994 and headquartered in Turku, Finland. The company specializes in developing innovative solutions for assay development and research applications, providing a range of products and services that include antibodies, antigens, and various biomarkers. HyTest's offerings are utilized across multiple clinical areas, such as cardiac markers, infectious diseases, metabolic syndrome, and veterinary diagnostics. By focusing on research and development, HyTest enables its clients to deliver accurate testing solutions in the in vitro diagnostic sector.

Artios Pharma Limited is a biotechnology company based in Cambridge, United Kingdom, that specializes in developing innovative cancer treatments targeting DNA damage response (DDR) pathways. Founded in 2016, the company is dedicated to creating first-in-class therapies that selectively kill cancer cells by exploiting their reliance on DDR mechanisms. Artios’ product pipeline includes a range of promising candidates, such as a therapy that targets DNA polymerase theta, a protein involved in DNA repair processes, and another program focusing on a novel DDR target. The company collaborates with prominent research organizations, including Cancer Research Technology, to enhance its development efforts and leverage expertise in DNA repair. Artios is led by a skilled team with extensive experience in drug discovery, positioning it to advance its next-generation DDR programs and contribute significantly to the field of cancer treatment.

SUSE is a global leader in open source solutions, providing reliable and enterprise-grade software to a diverse range of industries, including automotive, telecom, banking, healthcare, manufacturing, retail, and technology. With a strong focus on Enterprise Linux, Kubernetes Management, and Edge solutions, SUSE supports mission-critical workloads for over 60% of the Fortune 500 companies. The company emphasizes collaboration with partners and communities to empower customers to innovate across various environments, from data centers to the cloud and edge. SUSE offers consulting, blended services, and training and certification, primarily generating revenue from subscriptions. Headquartered in Nuremberg, Germany, SUSE employs nearly 2,000 people globally and derives a significant portion of its revenue from North America.

Azelis Group is a specialty chemicals distributor and innovation service provider that caters to the specialty chemicals and food ingredients industries. The company operates through several geographic segments, including EMEA, which encompasses Europe, the Middle East, and Africa; the Americas, which includes the United States, Canada, Mexico, and parts of South America; and Asia-Pacific, covering various countries in Asia and the Pacific region. Azelis leverages its extensive local knowledge and an international structure to offer a diverse range of products and services. The company emphasizes high levels of technical support and customized solutions to meet the specific needs of its clients. Its operations are supported by a corporate service center and headquarters located in Belgium.

Facile.it is an online price comparison platform based in Milan, Italy, specializing in various sectors including insurance, energy, telecommunications, loans, and banking. The platform enables users to compare prices and services from leading providers, facilitating significant savings on their expenses. By leveraging technology, Facile.it streamlines the process of finding the best market offers, allowing clients to focus on other important tasks while ensuring they secure competitive rates.

MediFox GmbH, founded in 1994 and headquartered in Hildesheim, Niedersachsen, Germany, specializes in developing software solutions for ambulatory nursing care service providers and nursing care homes. The company offers enterprise system software designed to support outpatient care services, inpatient facilities, and therapeutic practices. MediFox's software encompasses essential services such as resource and route planning, care and support documentation, management information systems, and administration services, including billing and factoring. By providing these tools, MediFox enables care providers to enhance their organizational structure and streamline their processes in response to evolving industry needs.

Dojo is a financial technology company that specializes in providing card payment solutions to small and medium-sized businesses in the UK and Ireland. The company offers a range of services, including contactless card machines, online payment systems, and integrated solutions, allowing over 100,000 businesses to accept payments in-store, online, via phone, and on the move. Founded in 2008 and based in London, Dojo focuses on delivering flexible and efficient payment processing options tailored to the needs of its clients. The company's offerings aim to enhance the payment experience for both merchants and their customers, thereby facilitating smoother transactions across various platforms.

Broadnet is Norway's foremost provider of fiber-based data communication, serving businesses, operators, and the public sector. With ownership by a leading private equity firm, Broadnet operates a comprehensive nationwide fiber network that spans 40,000 kilometers, connecting over 90 towns across the country. This extensive infrastructure enables Broadnet to offer robust security and stability for its clients' data communications. The company is currently engaged in an ambitious rollout of fiber services designed to enhance connectivity for Norwegian businesses, ensuring they can effectively connect with enterprises globally.

BBS Automation GmbH is a provider of automation solutions and engineering services, specializing in the design, development, manufacturing, and installation of automated assembly and testing systems. The company serves a diverse range of industries, including automotive, aerospace, life sciences, consumer goods, electronic devices, energy storage, and renewable energy. BBS Automation also offers leak detection, build-to-print services, and winding technology solutions, along with training and after-sales support. With nearly 550 employees, the company operates production sites in Germany, China, Malaysia, and the United States, partnering with prominent global clients. Founded in 1891 and headquartered in Garching bei München, Germany, BBS Automation is committed to delivering flexible and high-quality automation solutions for complex manufacturing and testing processes.

Iver is a Swedish managed IT services provider specializing in full IT outsourcing. The company offers a range of contracted services, including hosting, cloud management, and application management. By focusing on dedicated customer service and delivering high-quality IT solutions, Iver has established strong relationships with clients in Sweden and Norway. Additionally, Iver supports digital transformation through its information technology management services, which include secure data storage and access across both proprietary and public clouds. This approach enables businesses to enhance their market strategies, improve customer experiences, increase operational efficiency, and generate valuable insights from data.

Simplify Medical, Inc. is a medical device company specializing in the design, development, manufacturing, and marketing of cervical and lumbar artificial discs intended for spinal use. Founded in 2013 and based in Sunnyvale, California, it offers innovative products such as the Simplify Disc, a non-metallic, MRI-compatible artificial cervical disc that preserves motion while allowing for full diagnostic imaging without the need for traditional CT scans. This technology minimizes patient exposure to ionizing radiation and is tailored for skeletally mature patients undergoing reconstruction at one level from C3 to C7 following discectomy procedures. Simplify Medical markets its products through distributors in the United Kingdom, Germany, and other international markets. The company was previously known as Simplify Delaware, Inc. before rebranding in February 2015.

Inspired is a co-educational, non-denominational independent school group based in London, United Kingdom. It operates a network of schools across Europe, Australia, and Africa, including locations in Berkshire, Switzerland, Sydney, and multiple cities in South Africa, such as Cape Town, Johannesburg, Pretoria, and Somerset West. The schools cater to students aged 1 to 18, providing a nurturing and progressive academic environment aimed at fostering maximum potential in its students. Inspired focuses on creating a supportive educational atmosphere that encourages holistic development and personal growth.

Candidator is an IT company based in Sweden that specializes in delivering comprehensive information technology operations, telephony, and outsourcing services to businesses and organizations in the Nordic market. Emphasizing the motto "Make IT simple," Candidator focuses on building long-term relationships with its clients by offering high-quality service and effective IT solutions. The company provides a range of services, including IT consulting, website development, and tailored business modules, all aimed at enhancing security and operational efficiency while reducing costs for its customers.

Studienkreis is one of Germany's largest providers of professional tutoring services, operating nearly 1,000 tuition schools nationwide since its establishment in 1974. The company specializes in providing offline and digital tutoring aimed at primary and secondary school students, offering support across all major subjects through its proprietary teaching materials and scientifically backed learning methodologies. Studienkreis focuses on helping children and adolescents enhance their academic performance and achieve consistently good grades. In addition to addressing specific academic queries, the company emphasizes fostering independent learning skills and a sense of responsibility in students, thereby improving their overall confidence in their educational journey.

Aelin Therapeutics is a privately held Belgian biotherapeutics company founded in 2017, based in Heverlee. The company develops antibiotics and therapeutics using its proprietary Pept-in technology, which leverages protein aggregation to induce functional knockdown of target proteins. This approach allows for the rational design of novel biotherapeutics that can address undruggable human targets and combat resistant bacteria like Methicillin-resistant Staphylococcus aureus (MRSA). Aelin Therapeutics' platform offers a unique mode of action and intracellular target space, differentiating it from traditional small molecule drugs or protein-based therapeutics. The company's technology has shown applications in various areas including bacteria, cancer cells, fungi, viruses, and plant cells, with supporting preclinical Proof of Concept data published in high-impact journals such as Science.

Orphazyme develops innovative therapies for treating lysosomal storage diseases, a family of serious genetic disorders. Based in Copenhagen, Denmark, the company collaborates with leading academic institutions worldwide.

Epidemic Sound AB is a Swedish music company founded in 2009, specializing in providing royalty-free music for individuals and businesses globally. The company boasts a diverse catalog of over 30,000 tracks spanning more than 180 genres, including acoustic, classical, and electronic, among others. Epidemic Sound caters to a wide range of customers, including video creators, broadcasters, and production companies, by offering subscription services for unlimited music use or the option to license individual tracks outright. All music provided comes with comprehensive rights clearance for use across all platforms and countries without the need for reporting, ensuring a straightforward licensing process. Headquartered in Stockholm, with additional offices in major cities worldwide, Epidemic Sound aims to empower storytellers by providing high-quality soundtracks that enhance visual content.

Caiway is a telecom infrastructure company based in Naaldwijk, Netherlands, specializing in broadband connectivity for over 350,000 households and businesses. The company has expanded its operations in recent years by rolling out fiber networks to underserved municipalities and remote areas. As a regional internet service provider, Caiway offers a comprehensive suite of services, including cable television, broadband internet, and telephony, utilizing advanced cable and fiber infrastructure. Key regions within its operational footprint include Westland, Schiedam, and Almelo, where it aims to deliver reliable networking solutions to enhance connectivity for its customers.